J Geriatr Oncol
Dr. James Norman Atkins, MD
- Medicare services, 2024
- 528
- Medicare patients, 2024
- 246
- Part D claims, 2024
- 1,041
- Publications
- 37
- Clinical trials
- 10
- Practice address
- 1370 West D St, North Wilkesboro, NC 28659
- Practice phone
- Call (336) 651-8100
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Atkins' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. James Norman Atkins is a hematologist and oncologist in North Wilkesboro, North Carolina
Dr. Atkins practices at Wilkes Medical Center in North Wilkesboro, North Carolina, part of Advocate Health.
Dr. Atkins' NPI, 1104808476, was assigned on November 14, 2005. Dr. Atkins holds North Carolina license 22209.
- NPI
- 1104808476NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3173656345
- NPI enumeration date
- November 14, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (336) 651-8100
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 76
- Medical school graduation
- 1976
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. James Norman Atkins practices at Wilkes Medical Center in North Wilkesboro, North Carolina
Dr. Atkins' primary practice is Wilkes Medical Center, at 1370 West D St, North Wilkesboro, NC 28659 in Wilkes County. The practice phone is (336) 651-8100.
- Wilkes Medical Center1370 West D St, North Wilkesboro, NC 28659 · Wilkes CountyPhone(336) 651-8100
Source: Dmand AI Affiliation Data
Dr. James Norman Atkins is affiliated with 5 sites of care and 2 medical groups
Dr. Atkins' primary practice is Wilkes Medical Center in North Wilkesboro, North Carolina, part of Advocate Health. Dr. Atkins is also affiliated with Bristol Regional Medical Center. The medical group on file is Atrium Health Wake Forest Baptist. Dmand AI also links Dr. Atkins to 3 more hospitals and 1 medical group, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. James Norman Atkins' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Atkins practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Wilkes Medical Center | Available with a free account |
| +4 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Advocate Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. James Norman Atkins is one of 420 hematologists and oncologists in North Carolina
Hematology and oncology is Dr. Atkins' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Atkins is licensed in North Carolina.
Specialties and state licenses
- Hematology and oncology, North CarolinaPrimary
Hematologists and oncologists near Dr. Atkins
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. James Norman Atkins billed Medicare for 528 services in 2024
CMS data shows 528 Medicare services from Dr. Atkins across 5 procedure codes in 2024, all of them office visits, for 246 Medicare patients. Medicare paid $34,074 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Atkins' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 6172024: 52814%
Dr. Atkins compared with the North Carolina median for hematologists and oncologists, 2024
- Dr. Atkins
- North Carolina median
- Medicare services
- 528vs 45017% above
- Medicare patients
- 246vs 18037% above
- Part D claims
- 805vs 3242.5 times
Medians across 402 hematologists and oncologists in North Carolina with Dmand AI profiles that report each measure.
Dr. Atkins' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Atkins?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Atkins and other hematologists and oncologists in North Carolina.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. James Norman Atkins treated 246 Medicare patients in 2024, average age 75
CMS counts 246 Medicare patients who saw Dr. Atkins in 2024. The largest group is 75 to 84, with 92 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Atkins' median patient age at 73, with 76% women.
Dr. Atkins' Medicare patients by age, 2024
Dr. Atkins' Medicare patients by sex, 2024
- Women14860%
- Men9840%
Chronic conditions among Dr. Atkins' Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Cancer46%
- Arthritis44%
- Chronic kidney disease39%
- Diabetes37%
- Mood disorders30%
- Depression29%
Share of Medicare patients with each condition. A patient can have several.
Dr. Atkins' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women76%
- Men24%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. James Norman Atkins wrote 1,041 Medicare Part D claims in 2024
In 2024, Dr. Atkins wrote 1,041 Medicare Part D claims for 223 patients. 82% of them were for generic drugs. CMS names the drug for 805 of them, across 29 drugs with 11 or more claims each, at $1,688,122 in total drug cost. In 2023, CMS named 784 claims across 24 drugs.
Dr. Atkins' Part D claims by kind of drug, 2024
- Generic850 claims82%
- Brand-name191 claims18%
Dr. Atkins' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Atkins' Part D claims, 2024
- Opioids8%85 of 1,041 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 7842024: 8053%
Drugs named by CMS: 29 in 2024, 24 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. James Norman Atkins takes part in Medicare
Dr. Atkins accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. James Norman Atkins has 37 publications on record
Dmand AI links 37 papers to Dr. Atkins, published from 2010 to 2022. 2019 was the busiest year, with 6. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Colonic Neoplasms and Adenocarcinoma. Dr. Atkins has published most often in Cancer Genomics Proteomics. Dr. Atkins' most frequent co-authors are Norman Wolmark, MD, Charles David Blanke, MD and Eleftherios P. Mamounas, MD.
Dr. Atkins' papers by year, 2012 to 2022
Topics Dr. Atkins writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Colonic Neoplasms
- Adenocarcinoma
- Bevacizumab
- Biomarkers, Tumor
- Fluorouracil
- Gene Expression Regulation, Neoplastic
- Leucovorin
Dr. Atkins' most frequent co-authors
- Norman Wolmark, MD11 shared papers
- Charles David Blanke, MD8 shared papers
- Eleftherios P. Mamounas, MD8 shared papers
Recent publications by Dr. Atkins
See who Dr. Atkins researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Atkins works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. James Norman Atkins has worked on 10 clinical trials
Dmand AI links Dr. Atkins to 10 clinical trials, 7 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Breast Carcinoma In Situ, Breast Neoplasms and Melanoma. National Cancer Institute (NCI) sponsors the most, 7.
Clinical trials with Dr. Atkins by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- NonePhase 2: no trials
- 1Phase 2/3: 1 trial
- 7Phase 3: 7 trials
- NonePhase 4: no trials
Trials with no phase (devices, behavioral studies) are left out.
Conditions in Dr. Atkins' trials
- Breast Carcinoma In Situ
- Breast Neoplasms
- Melanoma
- Breast Diseases
- Nevi and Melanomas
Investigators on the most trials with Dr. Atkins
- Rakesh Gaur, FACP, MD, MPH7 shared trials
- Jeffrey L. Berenberg, MD5 shared trials
- Terrence P. Cescon, MD5 shared trials
Recent clinical trials with Dr. Atkins
A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women With Endocrine Responsive Breast Cancer Who Desire Pregnancy (opens in a new tab)
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors (opens in a new tab)
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer (opens in a new tab)
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma (opens in a new tab)
Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. James Norman Atkins received $2,102 in industry payments from 2016 to 2024
CMS Open Payments shows 83 general payments to Dr. Atkins from 31 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 75% of the total. Bristol-Myers Squibb Company paid the most, $253.
General payments to Dr. Atkins by program year, 2016 to 2024
General payments to Dr. Atkins by kind, 2016 to 2024
- Food and beverage$1,57175%
- Education$53125%
Companies that paid Dr. Atkins the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. James Norman Atkins's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. James Norman Atkins
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. James Norman Atkins' NPI number?
Dr. James Norman Atkins' NPI number is 1104808476. It was assigned on November 14, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. James Norman Atkins?
Dr. James Norman Atkins is a hematologist and oncologist in North Wilkesboro, North Carolina. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. James Norman Atkins practice?
Dr. Atkins practices at 1370 West D St, North Wilkesboro, NC 28659. Dr. Atkins' primary practice is Wilkes Medical Center in North Wilkesboro, North Carolina, part of Advocate Health. Dmand AI also links Dr. Atkins to 3 hospitals and 1 medical group.
What is Dr. James Norman Atkins' office phone number?
The practice phone on file for Dr. Atkins is (336) 651-8100.
What is Dr. James Norman Atkins' medical license number?
Dr. Atkins holds North Carolina license 22209.
Which hospitals is Dr. James Norman Atkins affiliated with?
Dr. Atkins practices at Wilkes Medical Center in North Wilkesboro, North Carolina. Dr. Atkins is also affiliated with Bristol Regional Medical Center. Dmand AI links Dr. Atkins to 3 more hospitals.
What medical group is Dr. James Norman Atkins part of?
Dr. Atkins is linked to Atrium Health Wake Forest Baptist. Dmand AI links Dr. Atkins to 1 more medical group.
Does Dr. James Norman Atkins accept Medicare?
Yes. CMS data shows Dr. Atkins billed Medicare for 528 services in 2024, and Dr. Atkins accepts Medicare assignment.
How many Medicare patients does Dr. James Norman Atkins see?
CMS counts 246 Medicare patients who saw Dr. Atkins in 2024, with an average age of 75.
What services does Dr. James Norman Atkins bill to Medicare?
In 2024, Dr. Atkins' most billed Medicare services were office visit, established patient (99213), office visit, established patient (99214) and office visit, established patient (99215).
Show 5 more questionsShow fewer questions
What drugs does Dr. James Norman Atkins prescribe most?
In 2024 Medicare Part D data, Dr. Atkins' most prescribed drugs by claims were Anastrozole, Ondansetron HCl and Prochlorperazine Maleate.
Has Dr. James Norman Atkins received payments from drug or device companies?
CMS Open Payments shows $2,102 in general payments to Dr. Atkins from 31 companies from 2016 to 2024. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. James Norman Atkins been practicing?
Dr. Atkins graduated from medical school in 1976, 50 years ago.
Does Dr. James Norman Atkins do research?
Dmand AI links 37 publications to Dr. Atkins, published from 2010 to 2022. Dr. Atkins has worked on 10 clinical trials.
Who does Dr. James Norman Atkins publish with?
Dr. Atkins' most frequent co-authors are Norman Wolmark, MD (11 shared papers), Charles David Blanke, MD (8 shared papers) and Eleftherios P. Mamounas, MD (8 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in North Carolina by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card